Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, Iowa City, and St Louis, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 984 people enrolled
- Started
- 27 Jun 2023
- Ended
- 15 Jul 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- PRESS Intervention
- Record updated
- 11 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Lowest EMS systolic blood pressure <110 mmHg
- Highest EMS pulse rate >90 beats per minute
- Highest EMS respiratory rate >20 breaths per minute
- EMS transport to a participating study ED/hospital
- At least one of the following present:; Lowest systolic blood pressure <90 mmHg; Age 40 years or greater; Hot temperature assessment or temp >38 degrees Celsius; Oxygen saturation <90%; Nursing home patient; Emergency Medical Dispatch classification = 'sick person'
Who cannot take part
- Patient left emergency department prior to being evaluated by a medical provider (inability to classify sepsis status)
- Any of the following EMS conditions present:; Trauma injury; Cardiac arrest; Psychiatric emergency; Toxic ingestion; Pregnant patient
- Inability to administratively link EMS and ED/hospital records
Where in United States
- Emory University HospitalAtlanta, United States
- University of IowaIowa City, United States
- Washington UniversitySt Louis, United States
About the trial
What the trial wants to find out
The primary purpose of this study is to evaluate the impact of an Emergency Medical Services (EMS) based sepsis screening and early warning protocol on the timing of early sepsis care in the Emergency Department (ED).
The 2 groups in the trial
- PRESS InterventionTreatment being tested
Study sites will participate in the intervention phase for 6 to 18 months, depending on the order of cluster randomization. Sites will switch from the baseline phase in approximately 6 month blocks, with all sites delivering the intervention for the final 6 months of the study.
- Standard of CareNo study treatment, for comparison
Study sites will participate in the standard of care phase to collect baseline data for 6 to 18 months, depending on the order of cluster randomization. All sites are in the baseline phase for the first 6 months then sites will switch one at a time, every 6 months, to the intervention phase of the study.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multicenter, Stepped Wedge, Cluster Randomized Study of a Prehospital Sepsis Protocol and Its Impact on Timely Antibiotic Administration in the Emergency Department and Subsequent Adverse Events
- Publications
- Record updated
- 11 August 2025